ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,533, issued on July 28, was assigned to Georgia Tech Research Corp. (Atlanta) and Emory University (Atlanta).

"Methods and compositions for noninvasive detection of organ transplant rejection" was invented by Gabriel A. Kwong (Atlanta), Andrew B. Adams (Atlanta), Quoc Mac (Atlanta) and David V. Mathews (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "An activity-based nanosensor composition for detecting protease activity comprising a cleavable detectable substrate and methods of use are disclosed."

The patent was filed on Jan. 13, 2022, under Application No. 17/574,947.

*For further information, including images, charts and tables, please ...